Establishment Labs (NASDAQ:ESTA) Hits New 12-Month Low – Here’s What Happened

Establishment Labs Holdings Inc. (NASDAQ:ESTA)’s share price reached a new 52-week low on Monday . The stock traded as low as $28.16 and last traded at $29.82, with a volume of 61010 shares. The stock had previously closed at $28.51.

Wall Street Analyst Weigh In

Separately, Stephens raised shares of Establishment Labs to a “strong-buy” rating in a research note on Monday, December 2nd. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average price target of $60.60.

Establishment Labs Stock Down 1.0 %

The stock has a market capitalization of $836.08 million, a price-to-earnings ratio of -11.47 and a beta of 1.12. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62. The firm’s fifty day simple moving average is $39.75 and its 200 day simple moving average is $41.89.

Institutional Investors Weigh In On Establishment Labs

Several institutional investors have recently added to or reduced their stakes in the stock. Simplify Asset Management Inc. raised its holdings in shares of Establishment Labs by 197.1% in the fourth quarter. Simplify Asset Management Inc. now owns 64,300 shares of the company’s stock valued at $2,962,000 after purchasing an additional 42,661 shares during the last quarter. KLP Kapitalforvaltning AS acquired a new position in shares of Establishment Labs during the 4th quarter worth about $161,000. Sei Investments Co. grew its holdings in shares of Establishment Labs by 22.3% in the 4th quarter. Sei Investments Co. now owns 42,471 shares of the company’s stock valued at $1,957,000 after acquiring an additional 7,731 shares in the last quarter. William Blair Investment Management LLC grew its holdings in shares of Establishment Labs by 44.1% in the 4th quarter. William Blair Investment Management LLC now owns 812,825 shares of the company’s stock valued at $37,447,000 after acquiring an additional 248,888 shares in the last quarter. Finally, Royce & Associates LP acquired a new stake in shares of Establishment Labs in the fourth quarter valued at about $4,862,000. 72.91% of the stock is owned by institutional investors.

About Establishment Labs

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.